BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 8527214)

  • 1. Retinoids as teratogens.
    Soprano DR; Soprano KJ
    Annu Rev Nutr; 1995; 15():111-32. PubMed ID: 8527214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teratology of retinoids.
    Collins MD; Mao GE
    Annu Rev Pharmacol Toxicol; 1999; 39():399-430. PubMed ID: 10331090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-selective retinoid agonists and teratogenic activity.
    Willhite CC; Dawson MI; Reichert U
    Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Teratogenic effects of vitamin A and its derivates].
    Guillonneau M; Jacqz-Aigrain E
    Arch Pediatr; 1997 Sep; 4(9):867-74. PubMed ID: 9345570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
    Willhite CC; Lovey A; Eckhoff C
    Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of metabolism and toxicokinetics in retinoid teratogenesis.
    Tzimas G; Nau H
    Curr Pharm Des; 2001 Jun; 7(9):803-31. PubMed ID: 11375780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of retinoids in vertebrate development.
    Means AL; Gudas LJ
    Annu Rev Biochem; 1995; 64():201-33. PubMed ID: 7574480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoids in embryonal development.
    Ross SA; McCaffery PJ; Drager UC; De Luca LM
    Physiol Rev; 2000 Jul; 80(3):1021-54. PubMed ID: 10893430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of retinoids in developmental toxicology. IV. Planar Cisoid conformational restriction.
    Willhite CC; Dawson MI
    Toxicol Appl Pharmacol; 1990 Apr; 103(2):324-44. PubMed ID: 2330592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-affinity relationships of retinoids with embryonic cellular retinoic acid-binding protein.
    Willhite CC; Jurek A; Sharma RP; Dawson MI
    Toxicol Appl Pharmacol; 1992 Jan; 112(1):144-53. PubMed ID: 1310166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of embryotoxicity by structural modification of the terminal group of cancer chemopreventive retinoids.
    Willhite CC; Shealy YF
    J Natl Cancer Inst; 1984 Mar; 72(3):689-95. PubMed ID: 6583452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical analysis for teratogenic sensitivity.
    Luecke RH; Wosilait WD; Young JF
    Teratology; 1997 Jun; 55(6):373-80. PubMed ID: 9294882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurobehavioral teratology of retinoids: a 50-year history.
    Adams J
    Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):895-905. PubMed ID: 20865785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of transplacental and maternal pharmacokinetics of retinoids during organogenesis with teratogenicity.
    Nau H
    Methods Enzymol; 1990; 190():437-48. PubMed ID: 2150873
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure.
    Arafa HM; Elmazar MM; Hamada FM; Reichert U; Shroot B; Nau H
    Arch Toxicol; 2000 Jan; 73(10-11):547-56. PubMed ID: 10663386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-toxicity relationships of the tetramethylated tetralin and indane analogs of retinoic acid.
    Howard WB; Willhite CC; Sharma RP
    Teratology; 1987 Dec; 36(3):303-11. PubMed ID: 3424219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
    Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinamides: hydrolytic conversion of retinoylglycine to retinoic acid in pregnant mice contributes to teratogenicity.
    Kochhar DM; Shealy YF; Penner JD; Jiang H
    Teratology; 1992 Feb; 45(2):175-85. PubMed ID: 1615427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral retinoids. What should the prescriber known about their teratogenic hazards among women of child-bearing potential?
    Mitchell AA
    Drug Saf; 1992; 7(2):79-85. PubMed ID: 1605903
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.
    Collins MD; Tzimas G; Hummler H; Bürgin H; Nau H
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):132-44. PubMed ID: 8048045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.